Key facts
- It has raised $5.0M; the latest was Early Stage VC in Feb 2026.
- Notable investors include Gaingels, Illumina Ventures, Adverb Ventures, Tenmile.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Oncko
- ·The full record, as it builds
Funding rounds
No funding rounds for Oncko are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oncko
Operator of a biotechnology research company intended to discover and develop combination therapies for cancer patients. The company is currently operating in a Stealth mode.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 4
- Website
- oncko.com/
- Ownership
- Privately Held (backing)
Oncko doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oncko shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oncko in its N-PORT filings yet. We sweep new filings monthly.